SCHEMBL658471

SCHEMBL658471

CCOC(=O)CC(c1ccccc1)c1cc2cc(Cl)ccc2o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.53
THRB P10828 2/20 0.53
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
ALOX5 P09917 1/20 0.44
LMNA P02545 5/20 0.42
ALDH1A1 P00352 4/20 0.42
TSHR P16473 1/20 0.42
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
KDM4E B2RXH2 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
GPR35 Q9HC97 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAOB P27338 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HPGD P15428 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL657972 0.88 THRB (0.45) TP53THRBKMT2AMEN1LMNA
SCHEMBL657858 0.85 KMT2A (0.48) KMT2AMEN1ALOX5LMNAALDH1A1
SCHEMBL9315814 0.77 TP53 (0.48) TP53THRBKMT2AMEN1ALOX5
SCHEMBL16595657 0.76 ALOX5 (0.49) TP53THRBKMT2AMEN1ALOX5
SCHEMBL7178642 0.76 ALDH1A1 (0.55) KMT2AMEN1LMNAALDH1A1TSHR
SCHEMBL658890 0.75 MAOB (0.47) KMT2ATAS1R3TAS1R1L3MBTL1MAOB
SCHEMBL20799424 0.75 TP53 (0.48) TP53THRBKMT2AMEN1LMNA
SCHEMBL10908208 0.74 ALDH1A1 (0.51) THRBKMT2AMEN1LMNAALDH1A1
SCHEMBL7384451 0.74 MAOB (0.43) TP53THRBALDH1A1KDM4EL3MBTL1
SCHEMBL7390110 0.73 THRB (0.53) TP53THRBALDH1A1TSHRTAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB TP53 417/4885THRB 1922/4885KMT2A 1777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.